Literature DB >> 18461616

GB virus type C infection in hemodialysis patients considering co-infection with hepatitis C virus.

S M Hosseini-Moghaddam1, H Keyvani, M Samadi, S M Alavian, M Mahdavimazdeh, S Daneshvar, Z Razzaghi.   

Abstract

GB virus type C is a well-known viral agent with capability of infecting patients undergoing hemodialysis. Liver enzyme levels in infected individuals have been reported to remain within the normal range. Simultaneous infection of GBV-C and other viral agents may occur due to common routes of transmission. A total of 104 hemodialysis patients living in Tehran were included in this case-control study (53 patients with HCV infection, group I; and 51 with no HCV infection, group II). Diagnosis was made by detection Anti-E(2) protein using ELISA and HCV-RNA using RT-PCR. History of HBV-infection, organ transplantation, depression, malignancies, chemotherapy, diabetes mellitus, thyroid disorders and chronic cutaneous disorders were considered. Patients were evaluated for high- risk behaviors such as intravenous drug injection, addiction or substance abuse. A total of 14 patients (13.6%) were GBV-C-infected. Four of them were co-infected with HCV. All patients with GBV-C infection had viral genotype 2. Thirteen patients (12%) had a history of multiple blood transfusions. Mean (+/-SD) age of GBV-C-infected patients was 48.7+/-13.8 years. Among GBV-C infected patients, three patients had a history of organ transplantation and three had a co-morbidity of diabetes mellitus. This study as the first case-control study to evaluate the association between GBV-C and HCV infection, to our knowledge, shows hemodialysis patients living in Tehran are infected with GBV-C with intermediate level of frequency. The association of GBV-C transmission with other viral blood-borne agents might be necessary.

Entities:  

Mesh:

Year:  2008        PMID: 18461616     DOI: 10.1002/jmv.21161

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

Review 1.  GBV-C: state of the art and future prospects.

Authors:  Maria Teresa Maidana Giret; Esper Georges Kallas
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

2.  Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil.

Authors:  Maria Teresa M Giret; João Luiz Miraglia; Maria Cecília Araripe Sucupira; Anna Nishiya; José Eduardo Levi; Ricardo S Diaz; Ester C Sabino; Esper G Kallas
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

3.  Genotyping and infection rate of GBV-C among Iranian HCV- infected patients.

Authors:  Reza Ghanbari; Mehrdad Ravanshad; Seyed Younes Hosseini; Ramin Yaghobi; Kiana Shahzamani
Journal:  Hepat Mon       Date:  2010-06-01       Impact factor: 0.660

Review 4.  Clinical and molecular aspects of human pegiviruses in the interaction host and infectious agent.

Authors:  Mehdi Samadi; Vahid Salimi; Mohammad Reza Haghshenas; Seyed Mohammad Miri; Seyed Reza Mohebbi; Amir Ghaemi
Journal:  Virol J       Date:  2022-03-09       Impact factor: 4.099

5.  Clinical practice guideline management of blood borne viruses within the haemodialysis unit.

Authors:  Elizabeth Garthwaite; Veena Reddy; Sam Douthwaite; Simon Lines; Kay Tyerman; James Eccles
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.